Allergy Therapeutics (AGY)

 

AGY Share PerformanceMore

52 week high32.60 11/12/15
52 week low17.25 26/09/16
52 week change -11.13 (-35.18%)
4 week volume3,623,592 06/11/16

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Allergy Therapeutics resolutions passed at AGM

Allergy Therapeutics has confirmed that all resolutions proposed at its annual general meeting were passed. At 8:58am: (LO...

Result of AGM

RNS Number: 1225Q Allergy Therapeutics PLC 24 November 2016 24 November 2016 Al l e r g y Th e r a p e u ti cs p l c (" A l l e r gy T he r a peu t i cs" or t he " C o m p a n y " ) Result of Annual General Meeting Allergy Therapeutics (AIM:AGY), the fully integrated pharmaceutical company specialising in allergy vaccines, announces that, at the Annual General M...

Allergy Therapeutics granted EU patent

Allergy Therapeutics has announced that the European Patent Office has granted a broad technology patent relating to the...

EU Patent Office grants patent for MCT

RNS Number: 0525O Allergy Therapeutics PLC 02 November 2016 2 November 2016 Al l e r g y Th e r a p e u ti cs p l c (" A l l e r gy T he r a peu t i cs" or t he " C o m p a n y " ) European Patent Office grants new and expanded patent underpinning Allergy Therapeutics' core Microcrystalline Tyrosine technology Patent already granted in the United Kingdom and...

Issue of equity in respect of exercise of options

RNS Number: 6473N Allergy Therapeutics PLC 27 October 2016 27 October 2016 Al l e r g y Th e r a p e u ti cs p l c (" A l l e r gy T he r a peu t i cs" or t he " C o m p a n y " ) Issue of equity in respect of the exercise of options Allergy Therapeutics announces the issue and allotment of80,000new ordinary shares of 0.1p each in the capital of the Company ("Ordinary S...

Annual Report and Accounts

RNS Number: 3117N Allergy Therapeutics PLC 24 October 2016 24 October 2016 Al l e r g y Th e r a p e u ti cs p l c (" A l l e r gy T he r a peu t i cs" or t he " C o m p a n y " ) Annual Report and Accounts Allergy Therapeutics (AIM:AGY), the fully integrated pharmaceutical company specialising in allergy vaccines, announces that the Annual Report and Accounts f...

Share of the week: Tipped to double again

Just weeks after we covered its final results, this company's share price has surged and could rise much further, according...

New data from novel adjuvant system

RNS Number: 0772M Allergy Therapeutics PLC 10 October 2016 10 October 2016 Al l e r g y Th e r a p e u ti cs p l c (" A l l e r gy T he r a peu t i cs" or t he " C o m p a n y " ) Allergy Therapeutics presents enhanced efficacy data in a malaria vaccine model with its novel adjuvant system Data to be presented today at the World Vaccine Congress demonstrates signific...

Fundamental DataMore

EPS-2.29
Dividend yield0 %

Equity Research (AGY)

Allergy Therapeutics plc
15/11/2016
InnovaDerma* (IDP.L) 107.5p £10.98m Strong news flow this week from the main market listed  UK developer of 'at-home' and clinically proven treatments for hair loss, hair care, self-...
hardman & co
Allergy Therapeutics plc
26/09/2016
AGY is a long-established specialist in the prevention, diagnosis and treatment of allergies. Pollinex Quattro continues to gain market share despite being available in Europe only on a ‘Named...
hardman & co
Allergy Therapeutics plc
07/06/2016
AGY is a long-established specialist in the prevention, diagnosis and treatment of allergies. It’s lead product, Pollinex Quattro is available in Europe only on a ‘Named Patient’ basis. However,...

Latest discussion posts More

  • Re: Panmure November 2nd it's just a dream

    Dave Todays price is about right impo. We moved up[ recently on the back of the rec from interactive investor which was future thinking. I will be happy once we have ...
    10-Nov-2016
    Baffler
  • Panmure November 2nd it's just a dream

    Baffler how often have we seen a note like this,only to see the share head back south again,I brought back in at just 0.9 pence two & half years ago , the brokers guide price ...
    10-Nov-2016
    d gaser
  • Panmure November 2nd

    Allergy Therapeutics PLC (LON:AGY) Rating The financial company have set price target of GBX 53.00 on Allergy Therapeutics PLC (LON:AGY) shares. This is 130.43% from the ...
    10-Nov-2016
    Baffler

Users' HoldingsMore

Users who hold Allergy Therapeutics also hold..
LLOYDS GRP.26%
BP19%
GLAXOSMITHKLINE15%
BARCLAYS15%
NATIONAL GRID13%

Codes & Symbols

ISINGB00B02LCQ05
SymbolsAGY, LSE:AGY, AGY.L, AGY:LN, LON:AGY, XLON:AGY